COTEMPLA XR-ODT is a once-daily medication taken in the morning for the treatment of ADHD in patients 6 to 17 years of age.

2023年4月4日 · Cotempla XR-ODT is a stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) in children. It contains a central nervous system (CNS) stimulant called methylphenidate.

Take this medication by mouth as directed by your doctor, usually once daily in the morning. You may take this medication with or without food, but it is important to choose one way and take...

2024年6月8日 · COTEMPLA XR-ODT is an extended-release orally disintegrating tablet intended for once daily administration. COTEMPLA XR-ODT contains approximately 25% immediate-release and 75% extended-release methylphenidate. Methylphenidate is ionically-bound to the sulfonate of polystyrenesulfonate particles.

COTEMPLA XR-ODT is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age. (1)...

2024年11月7日 · Detailed dosage guidelines and administration information for Cotempla XR-ODT (methylphenidate). Includes dose adjustments, warnings and precautions.

2025年2月14日 · Cotempla XR-ODT (methylphenidate) was approved in June 2017 for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age. It is not approved for use in adults. Cotempla XR-ODT tablets are administered once daily in …

2024年2月1日 · Cotempla (methylphenidate) is a medication used in the treatment of attention deficit hyperactivity disorder (ADHD) in those 6 years and older. It is an orally dissolving tablet that is taken once in the morning and lasts all day in due part of its extended-release formulation.

2024年7月15日 · Cotempla XR ODT (methylphenidate ER) is a stimulant medication. It's approved for children ages 6 to 17 years old with ADHD (attention deficit-hyperactivity disorder). Cotempla XR ODT (methylphenidate ER) comes as an orally disintegrating tablet (ODT) that's dissolved on the tongue once per day in the morning.

Cotempla XR-ODT (Generic Name: methylphenidate) is the first methylphenidate-based extended-release orally disintegrating tablet for the treatment of ADHD in children between the ages of 6 and 17.